These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2231218)

  • 1. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia.
    Ferrazzini G; Klein J; Sulh H; Chung D; Griesbrecht E; Koren G
    J Pediatr; 1990 Nov; 117(5):823-6. PubMed ID: 2231218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
    Levinsen M; Shabaneh D; Bohnstedt C; Harila-Saari A; Jonsson OG; Kanerva J; Lindblom A; Lund B; Andersen EW; Schmiegelow K;
    Eur J Haematol; 2012 Jan; 88(1):78-86. PubMed ID: 21854453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
    Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS
    J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole.
    Kwon OC; Lee JS; Kim YG; Lee CK; Yoo B; Hong S
    Clin Rheumatol; 2018 Dec; 37(12):3215-3220. PubMed ID: 29383453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate.
    Watts CS; Sciasci JN; Pauley JL; Panetta JC; Pei D; Cheng C; Christensen CM; Mikkelsen TS; Pui CH; Jeha S; Relling MV
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):449-52. PubMed ID: 27322715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients.
    Skoloda D; Newman M; Norman H; Ziggas JE; Ambinder RF
    JCO Oncol Pract; 2024 May; 20(5):673-677. PubMed ID: 38382007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction.
    Paap CM; Nahata MC
    DICP; 1989 Sep; 23(9):646-54. PubMed ID: 2678767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
    Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
    Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States.
    Davis SA; Krowchuk DP; Feldman SR
    South Med J; 2014 May; 107(5):292-3. PubMed ID: 24937727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
    Autmizguine J; Melloni C; Hornik CP; Dallefeld S; Harper B; Yogev R; Sullivan JE; Atz AM; Al-Uzri A; Mendley S; Poindexter B; Mitchell J; Lewandowski A; Delmore P; Cohen-Wolkowiez M; Gonzalez D;
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
    Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
    Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
    Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
    J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis.
    Rungoe C; Malchau EL; Larsen LN; Schroeder H
    Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.
    Weinthal J; Frost JD; Briones G; Cairo MS
    J Clin Oncol; 1994 Jan; 12(1):136-40. PubMed ID: 8270969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
    Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
    Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
    Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of co-trimoxazole on methotrexate pharmacokinetics in children with acute lymphoblastic leukemia.
    Beach BJ; Woods WG; Howell SB
    Am J Pediatr Hematol Oncol; 1981; 3(2):115-9. PubMed ID: 6975580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    Nazir HF; Elshinawy M; AlRawas A; Khater D; Zadjaly S; Wali Y
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):203-208. PubMed ID: 28234744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
    Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
    Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of co-medications and potential risk factors of high-dose methotrexate-mediated acute hepatotoxicity in patients with osteosarcoma.
    Wang SF; Huang KW; Chou YC; Lee HC; Wu PK; Chen WM; Hung GY; Chang YL
    Cancer Med; 2023 Jun; 12(11):12354-12364. PubMed ID: 37062070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.